Heading colour
This is a bit tricky because we use a gradient for core heading styles but I’ve sorted something that works in the front and back end.
Blue heading
Orange heading
Grey heading
Heading 5 blue
Heading 5 no colour
Test
Button styles and icons
Includes a couple of fixes for button styles and the option to add a FA icon after button text.
Events query loop by event date
Have added AQL block variation for the query block to achieve this.
-
The Celtic Challenge 2025
If you’re a cycling enthusiast we’ve some great news: The Celtic Challenge returns but this year we are headed to Ireland! Following on from a fantastic trip across Scotland last year we have decided to organise a beautiful 445 mile cycle going ‘End to End’…
-
Royal Parks Half Marathon 2025
Take in London’s famous landmarks and leafy parks when you run the Royal Parks Half Marathon, all to raise vital funds for Cure Parkinson’s. The incredible 13.1 mile route takes you through four of the eight Royal Parks – Hyde Park, Green Park, St James’s…
-
Ultra Challenge Series 2025
Push yourself further – and take on a 10km, 25km, 50km 75km or even a 100km Ultra Challenge in 2025! Looking for a challenge – to test yourself, to get in shape, or bond with friends on a weekend adventure? If so, an Ultra Challenge®…
Sticky block
Sticky blocks are enabled. To make a custom block sticky, first group it and apply sticky positioning to the parent.
Cell-replacement therapy in Parkinson’s involves altering stem cells into dopamine producing nerve cells (or dopaminergic neurons) and transplanting them into a person with Parkinson’s brain to replace dying or lost neurons.
STEM-PD, a cell-replacement trial for Parkinson’s, releases latest update
The STEM-PD trial has recently released an update, which indicates the team is proceeding to the next trial stage based on early positive safety data.
Webinar: Stem cell research for Parkinson’s – the latest updates
The next instalment of this quarterly webinar series will discuss the latest news in cell replacement therapies for Parkinson’s with Edinburgh University’s Professor Tilo Kunath as chair.
Aspen starts phase 1 stem cell transplant clinical trial
An experimental treatment for Parkinson’s involves the replacement of the lost dopamine neurons by transplanting new cells into the brain. Biotech company Aspen Neuroscience will soon be starting a…
Positive phase 1 results for BlueRock
BlueRock Therapeutics has reported positive results from the phase 1 trial of its cell-replacement therapy for Parkinson’s
Research Update Meeting Spring 2023 – recorded to watch again
Our popular and much-awaited research update meeting brought together two leading clinicians to report on their individual area of expertise for Parkinson’s. It’s available to watch again!
New biotech company focused on cell transplantation for Parkinson’s
Biotech company Ryne Bio has received a large research grant from CIRM to develop their late-stage preclinical cell transplantation procedure for Parkinson’s.
STEM-ing the progression of Parkinson’s
An exciting new clinical trial called STEM-PD is due to start in Sweden and the UK which will focus on stem cell transplantation as a potential treatment for Parkinson’s.
NECTAR 2021
The Network for European CNS Transplantation and Restoration (NECTAR) was founded over 25 years ago. Here, Dr Simon Stott presents a brief update on the events at NECTAR 2021.
More data from the ‘Blue Rockers’
BlueRock Therapeutics has published two preclinical research reports outlining the cell culturing method that they are taking into clinical trials.
Cell Replacement Therapy – TRANSEURO
TRANSEURO, involving a consortium of scientists led by Professor Roger Barker in Cambridge and funded in part by Cure Parkinson’s and the EU, has developed a clear pathway to…
Astrocytes to dopamine neurons in one step
The brain is made up of multiple types of cells. There are the neurons that conduct much of the cognitive functioning in the brain, Then there are a collection…
GDNF and cell transplantation: dual therapies for Parkinson’s
Parkinson’s is a complex condition and it is becoming increasingly clear that the future of disease-modifying therapies for Parkinson’s will rely on the use of multiple treatment approaches, as…
The rationale for the TRANSEURO study
The TRANSEURO study is part-funded by Cure Parkinson’s and is investigating dopamine cell replacement therapy as a restorative treatment for people with Parkinson’s. It is being coordinated by Professor…